# Liraglutide Treatment in Patients With Maturity-onset Diabetes of the Young (MODY)

> **NCT07029009** · PHASE2 · RECRUITING · sponsor: **Mansa** · enrollment: 50 (estimated)

## Conditions studied

- Maturity Onset Diabetes of the Young

## Interventions

- **DRUG:** Liraglutide

## Key facts

- **NCT ID:** NCT07029009
- **Lead sponsor:** Mansa
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-08
- **Primary completion:** 2026-08
- **Final completion:** 2027-01
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2025-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07029009

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07029009, "Liraglutide Treatment in Patients With Maturity-onset Diabetes of the Young (MODY)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07029009. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*